These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 1689854)

  • 1. Positive stem cell selection--basic science.
    Civin CI; Strauss LC; Fackler MJ; Trischmann TM; Wiley JM; Loken MR
    Prog Clin Biol Res; 1990; 333():387-401; discussion 402. PubMed ID: 1689854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of anti-CD33 blocked ricin immunotoxin on the capacity of CD34+ human marrow cells to establish in vitro hematopoiesis in long-term marrow cultures.
    La Russa VF; Griffin JD; Kessler SW; Cutting MA; Knight RD; Blattler WA; Lambert JM; Wright DG
    Exp Hematol; 1992 May; 20(4):442-8. PubMed ID: 1373688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD34-positive cell selection by immunomagnetic beads and chymopapain.
    Silvestri F; Banavali S; Yin M; Gopal V; Savignano C; Baccarani M; Preisler HD
    Haematologica; 1992; 77(4):307-10. PubMed ID: 1385276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-kit is expressed by primitive human hematopoietic cells that give rise to colony-forming cells in stroma-dependent or cytokine-supplemented culture.
    Simmons PJ; Aylett GW; Niutta S; To LB; Juttner CA; Ashman LK
    Exp Hematol; 1994 Feb; 22(2):157-65. PubMed ID: 7507857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CD34 hemopoietic progenitor cell associated antigen: biology and clinical applications.
    Silvestri F; Banavali S; Baccarani M; Preisler HD
    Haematologica; 1992; 77(3):265-73. PubMed ID: 1385274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of adult human marrow hematopoietic progenitors highly enriched by two-color cell sorting with My10 and major histocompatibility class II monoclonal antibodies.
    Lu L; Walker D; Broxmeyer HE; Hoffman R; Hu W; Walker E
    J Immunol; 1987 Sep; 139(6):1823-9. PubMed ID: 3114377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between bone marrow and G-CSF-mobilized peripheral blood allografts undergoing clinical scale CD34+ cell selection.
    Hassan HT; Zeller W; Stockschläder M; Krüger W; Hoffknecht MM; Zander AR
    Stem Cells; 1996 Jul; 14(4):419-29. PubMed ID: 8843543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood.
    Van Epps DE; Bender J; Lee W; Schilling M; Smith A; Smith S; Unverzagt K; Law P; Burgess J
    Blood Cells; 1994; 20(2-3):411-23. PubMed ID: 7538347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An improved panning technique for the selection of CD34+ human bone marrow hematopoietic cells with high recovery of early progenitors.
    Cardoso AA; Watt SM; Batard P; Li ML; Hatzfeld A; Genevier H; Hatzfeld J
    Exp Hematol; 1995 May; 23(5):407-12. PubMed ID: 7536682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation.
    Novitzky N; Mohamed R
    Exp Hematol; 1995 Dec; 23(14):1661-6. PubMed ID: 8542962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CD34+ cells in the autotransplant of bone marrow and peripheral blood].
    Silvestri F; Baccarani M
    Recenti Prog Med; 1992 Feb; 83(2):89-92. PubMed ID: 1380174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-clinical evaluation of anti-lacto-N-fucopentaose III (CD15) monoclonal antibodies for ex vivo bone marrow purging in acute myeloid leukemia.
    Guyotat D; Shi ZH; Campos L; Rabat M; Bonnier S; Poncelet P; Laurent JC; Fiere D
    Bone Marrow Transplant; 1990 Dec; 6(6):385-90. PubMed ID: 1982926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell selection--clinical experience.
    Berenson RJ; Bensinger WI; Hill R; Andrews RG; Garcia-Lopez J; Kalamasz DF; Still BJ; Buckner CD; Bernstein ID; Thomas ED
    Prog Clin Biol Res; 1990; 333():403-10; discussion 411-3. PubMed ID: 1689855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
    Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
    Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Counterflow centrifugation allows addition of appropriate numbers of T cells to allogeneic marrow and blood stem cell grafts to prevent severe GVHD without substantial loss of mature and immature progenitor cells.
    Preijers FW; van Hennik PB; Schattenberg A; Ruijs P; Ploemacher RE; de Witte T
    Bone Marrow Transplant; 1999 May; 23(10):1061-70. PubMed ID: 10373074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD34 positive cell selection by immunomagnetic techniques.
    Bigas A; Amill B; Canals C; Tugues D; García J
    Prog Clin Biol Res; 1992; 377():545-51. PubMed ID: 1279723
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of CD34+ bone marrow cells purified by immunomagnetic and immunoadsorption cell separation techniques.
    Firat H; Giarratana MC; Kobari L; Poloni A; Bouchet S; Labopin M; Gorin NC; Douay L
    Bone Marrow Transplant; 1998 May; 21(9):933-8. PubMed ID: 9613787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methodologies to estimate circulating hematopoietic progenitors for autologous transplantation in cancer patients.
    Ravagnani F; Siena S; Bregni M; Brando B; Belli N; Lansdorp PM; Notti P; Pellegris G; Gianni AM
    Haematologica; 1991 Mar; 76 Suppl 1():46-9. PubMed ID: 1713874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
    Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
    J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.